05.08.2022 - RTHM collaborating on Tollovid 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and Tel Aviv, ISRAEL, Aug. 05, 2022 (GLOBE NEWSWIRE) - ... Seite 1